Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNV”

390 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 390 results

Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Early research (Phase 1)Study completedNCT01154062
What this trial is testing

Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
GlaxoSmithKline 15
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Large-scale testing (Phase 3)Looking for participantsNCT07482176
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 284
Not applicableStudy completedNCT01073592
What this trial is testing

Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00220805
What this trial is testing

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Grifols Therapeutics LLC 96
Large-scale testing (Phase 3)UnknownNCT00260403
What this trial is testing

TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal Neovascularization
St. Erik Eye Hospital 140
Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Not applicableUnknownNCT01972802
What this trial is testing

International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study

Who this might be right for
Evaluate the Association Between Certain Environmental Exposures (e.g. Cigarette Smoking, Alcohol Drinking, Betel Nut Chewing…) and Head and Neck CancersAssess the Effect of Genetic Factors, Including Both SNP and Copy Number Variation (CNV) Through Analysis of Both Main Effect and Gene-gene Interaction
National Taiwan University Hospital 900
Early research (Phase 1)UnknownNCT00855608
What this trial is testing

Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study

Who this might be right for
UveitisDiabetic RetinopathyChoroidal Neovascularization
Rafic Hariri University Hospital 15
Early research (Phase 1)Study completedNCT03249740
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 32
Testing effectiveness (Phase 2)Study completedNCT01884597
What this trial is testing

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)

Who this might be right for
PCVPolypoidal Choroidal Vasculopathy
Hawaii Pacific Health 24
Post-approval studies (Phase 4)Study completedNCT03117634
What this trial is testing

An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Who this might be right for
Age Related Macular DegenerationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 54
Large-scale testing (Phase 3)Study completedNCT01948830
What this trial is testing

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 650
Not applicableStudy completedNCT02175940
What this trial is testing

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularizationVEGF Aqueous LevelPEDF Aqueous Level
Università degli Studi di Brescia 40
Not applicableStudy completedNCT04912752
What this trial is testing

Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression

Who this might be right for
Migraine
University of Gaziantep 200
Post-approval studies (Phase 4)Study completedNCT01006538
What this trial is testing

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Who this might be right for
Macular Degeneration
King's College Hospital NHS Trust 363
Not applicableStudy completedNCT04075188
What this trial is testing

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Who this might be right for
Choroidal NeovascularizationChoroid Disease
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Load More Results